Can Fite Biopharma Ltd ADR (CANF)

Official site

HEALTHCARE • BIOTECHNOLOGY • AMEX

$1.93

-0.02 (-1.03%)

Market Cap: $5.85M

Last updated: Oct 16, 2026 at 1:54 PM ET

Earnings

Performance (10Y)

Beat Rate

55%(17/31)

Avg Surprise

-10066.52%

Streak

2 Q

Upcoming Estimates

Period ending Jun 30, 2026

EPS Consensus$-0.51

Range$-0.51 - $-0.51

1 analysts

EPS RevisionsNo revisions (7d)No revisions (30d)

EPS Estimate DriftChange to current

90d ago$-0.22-131.8%

60d ago$-0.45-13.3%

30d ago$-0.510.0%

7d ago$-0.510.0%

Current$-0.51

Revenue Consensus

Range$0 - $0

0 analysts

Period ending Sep 30, 2026

EPS Consensus$N/A

Revenue Consensus

Range$0 - $0

0 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.10	$-0.10 - $-0.10	-	-	1	-	-
Sep 30, 2026Sep 26EST	-	N/A	-	-	-	-	-	-
Jun 30, 2026Jun 26EST	-	$-0.51	$-0.51 - $-0.51	-	-	1	No revisions (30d)	-
Dec 31, 2025Dec 25 Reported Mar 26, 2026Reported Mar 26	$N/A	$-2.80	$-2.80 - $-2.80	N/A	Beat	1	0 1 30d	-
Sep 30, 2025Sep 25 Reported Sep 30, 2025Reported Sep 30	$N/A	$-2.80	$-2.80 - $-2.80	N/A	Beat	1	0 1 30d	-
Jun 30, 2025Jun 25 Reported Aug 28, 2025Reported Aug 28	$0.00	N/A	-	+100.00%	Beat	1	0 1 30d	-
Mar 31, 2025Mar 25 Reported Apr 14, 2025Reported Apr 14	$0.00	N/A	-	+100.00%	Beat	1	0 1 30d	-
Dec 31, 2024Dec 24 Reported Dec 31, 2024Reported Dec 31	$N/A	$-0.25	-	N/A	Beat	0	No revisions (30d)	-
Sep 30, 2024Sep 24 Reported Dec 26, 2024Reported Dec 26	$N/A	$-0.24	-	N/A	Beat	-	-	-
Jun 30, 2024Jun 24 Reported Sep 26, 2024Reported Sep 26	$N/A	$-0.22	$-0.22 - $-0.22	N/A	Beat	0	No revisions (30d)	-
Mar 31, 2024Mar 24 Reported Jun 27, 2024Reported Jun 27	$N/A	$-0.52	$-0.52 - $-0.52	N/A	Beat	0	No revisions (30d)	-
Dec 31, 2023Dec 23 Reported Mar 28, 2024Reported Mar 28	$-60.00	$-7.40	$-7.51 - $-7.30	-710.81%	Miss	2	No revisions (30d)	-5303.9%
Sep 30, 2023Sep 23 Reported Nov 30, 2023Reported Nov 30	$-0.44	N/A	-	+94.88%	Beat	2	No revisions (30d)	+99.3%
Jun 30, 2023Jun 23 Reported Aug 31, 2023Reported Aug 31	$-0.42	N/A	-	+97.10%	Beat	1	No revisions (30d)	+47.5%
Mar 31, 2023Mar 23 Reported Jun 1, 2023Reported Jun 1	$-0.65	N/A	-	+98.29%	Beat	2	No revisions (30d)	+27.8%
Dec 31, 2022Dec 22 Reported Mar 30, 2023Reported Mar 30	$-1.11	$-0.09	$-0.91 - $0.49	-1180.62%	Miss	3	No revisions (30d)	+63.0%
Sep 30, 2022Sep 22 Reported Nov 25, 2022Reported Nov 25	$-60.00	$-21.00	$-21.03 - $-20.96	-185.71%	Miss	3	No revisions (30d)	+0.0%
Jun 30, 2022Jun 22 Reported Aug 25, 2022Reported Aug 25	$-0.80	N/A	-	+95.29%	Beat	-	-	+98.7%
Mar 31, 2022Mar 22 Reported May 26, 2022Reported May 26	$-0.90	N/A	-	+96.79%	Beat	2	1 0 30d	+25.0%
Dec 31, 2021Dec 21 Reported Mar 24, 2022Reported Mar 24	$-3.00	$-1.80	$-1.80 - $-1.80	-66.67%	Miss	1	No revisions (30d)	+0.0%
Sep 30, 2021Sep 21 Reported Nov 26, 2021Reported Nov 26	$-60.00	$-0.90	$-0.90 - $-0.90	-6566.67%	Miss	2	No revisions (30d)	-25.6%
Jun 30, 2021Jun 21 Reported Aug 26, 2021Reported Aug 26	$-60.00	$-10.67	$-10.69 - $-10.66	-462.32%	Miss	2	No revisions (30d)	+0.0%
Mar 31, 2021Mar 21 Reported May 27, 2021Reported May 27	$-1.20	N/A	-	+96.84%	Beat	-	-	+99.3%
Dec 31, 2020Dec 20 Reported Mar 25, 2021Reported Mar 25	$-3.00	$-2.10	$-2.11 - $-2.09	-42.86%	Miss	2	No revisions (30d)	-588.9%
Sep 30, 2020Sep 20 Reported Nov 30, 2020Reported Nov 30	$-47.78	$-48.00	$-48.01 - $-48.00	+0.46%	Beat	2	No revisions (30d)	+73.5%
Jun 30, 2020Jun 20 Reported Aug 27, 2020Reported Aug 27	$-60.00	$-72.00	$-72.03 - $-71.97	+16.67%	Beat	2	No revisions (30d)	+75.0%
Mar 31, 2020Mar 20 Reported Jun 1, 2020Reported Jun 1	$-180.00	$-118.00	-	-52.54%	Miss	-	-	+25.0%
Dec 31, 2019Dec 19 Reported Mar 27, 2020Reported Mar 27	$-0.44	N/A	-	+51.07%	Beat	1	No revisions (30d)	+84.3%
Sep 30, 2019Sep 19 Reported Nov 29, 2019Reported Nov 29	$-180.00	$-156.00	$-156.15 - $-155.85	-15.38%	Miss	2	No revisions (30d)	-133828.6%
Jun 30, 2019Jun 19 Reported Aug 30, 2019Reported Aug 30	$-240.00	$-330.00	-	+27.27%	Beat	-	-	-33.3%
Mar 31, 2019Mar 19 Reported May 29, 2019Reported May 29	$-240.00	$-390.00	-	+38.46%	Beat	-	-	+20.0%
Dec 31, 2018Dec 18 Reported Mar 28, 2019Reported Mar 28	$-2.78	$-0.07	$-0.07 - $-0.07	-3871.43%	Miss	0	No revisions (30d)	+73.5%
Sep 30, 2018Sep 18 Reported Nov 30, 2018Reported Nov 30	$-0.13	$-0.06	$-0.06 - $-0.06	-124.00%	Miss	0	No revisions (30d)	+99.9%
Jun 30, 2018Jun 18 Reported Aug 31, 2018Reported Aug 31	$-180.00	$-0.06	$-0.06 - $-0.06	-299900.00%	Miss	1	1 0 30d	+0.0%
Mar 31, 2018Mar 18 Reported Jun 1, 2018Reported Jun 1	$-300.00	$-240.00	$-240.00 - $-239.99	-25.00%	Miss	2	No revisions (30d)	-150.0%
Dec 31, 2017Dec 17 Reported Mar 23, 2018Reported Mar 23	$-10.50	$-9.00	$-9.01 - $-8.99	-16.67%	Miss	2	No revisions (30d)	-900.0%
Sep 30, 2017Sep 17 Reported Nov 27, 2017Reported Nov 27	$-120.00	N/A	-	+66.67%	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Sep 1, 2017Reported Sep 1	$-180.00	$-270.00	-	+33.33%	Beat	-	-	-
Mar 31, 2017Mar 17 Reported May 30, 2017Reported May 30	$-120.00	N/A	-	+55.56%	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Mar 31, 2017Reported Mar 31	$-1.05	N/A	-	+90.00%	Beat	-	-	-

Dividends

Dividend Metrics

Forward Yield0.00%

Forward Annual Dividend$0.00

No dividend payments in the selected period.

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	-0.75x	FCF Yield	-132.82%
Profitability
Profit Margin	0.00%	Operating Margin	-2317.00%
ROE	-211.40%	ROIC	-156.81%
Financial Health
Debt/Equity	0.01x	Interest Coverage	N/A
Current Ratio	3.60x	Quick Ratio	3.60x
Trading Statistics
Beta	-0.02	Avg Volume	40.75K
52-Week High	$10.99	52-Week Low	$1.90

Technical Indicators Dashboard

Moving Averages

SMA 10$2.05

SMA 20$2.13

SMA 50$2.65

SMA 200$3.35

EMA 10$2.03

EMA 20$2.15

EMA 50$2.49

EMA 200$4.56

MACD

Line: -0.18Signal: -0.19Hist: 0.01

ADX

ADX: 46.2+DI: 7.6-DI: 30.3

Aroon & PSAR

Aroon Up12.0

Aroon Down88.0

PSAR$2.14

Bollinger Bands

Upper Band$2.36

Lower Band$1.90

%B Position2148%(Upper)

Band Width0.07

RSI (14-Day)

Oversold

27.1

Momentum Oscillators

Stoch %K11.7

Stoch %D9.8

Williams %R-91.9

ROC (10d)-12.3%

Momentum-0.27

CCI (20d)-154.6

MFI (14d)25.8

Volatility Measures

ATR (14d)$0.10(5.1%)

StdDev (20d)0.11

Hist Vol32.8%(Moderate)

Volume Flow

VWAP$1.93

OBV575.0M

AD Line88.6B

CMF (20d)-0.410

Volume Metrics

Avg Vol (20d)35.9K

Vol Ratio0.5x

VWMA (20d)$2.13

Pivot Points

R3$2.08

R2$2.04

R1$2.00

Pivot Point$1.95

S1$1.91

S2$1.87

S3$1.82

Advanced Oscillators

TSI-42.30

Ultimate Osc32.6

KST-204.14

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$101,000	$101,000	$101,500	$101,500	$101,000	$101,000	$179,000	$179,000	$158,000	$158,000	$155,000	$196,000
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$101,000	$101,000	$101,500	$101,500	$101,000	$101,000	$179,000	$179,000	$158,000	$158,000	$155,000	$196,000

Operating Expenses	$2.44M	$2.44M	$2.63M	$2.63M	$2.55M	$2.55M	$2.20M	$2.20M	$2.21M	$2.21M	$1.99M	$2.06M
R&D	$1.73M	$1.73M	$1.83M	$1.83M	$1.52M	$1.52M	$1.44M	$1.44M	$1.44M	$1.44M	$1.27M	$1.30M
SG&A	$713,000	$713,000	$798,000	$798,000	$1.03M	$1.03M	$761,000	$761,000	$762,500	$762,500	$722,000	$762,000
Operating Income	$-2,340,000	$-2,340,000	$-2,526,000	$-2,526,000	$-2,449,000	$-2,449,000	$-2,017,999	$-2,017,999	$-2,047,000	$-2,047,000	$-1,834,000	$-1,865,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$14,000	$3,000
Income Before Tax	$-2,300,500	$-2,300,500	$-2,476,000	$-2,476,000	$-2,438,000	$-2,438,000	$-1,961,500	$-1,961,500	$-1,978,500	$-1,978,500	$-1,652,000	$-1,762,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$-3,750	$-3,500

Net Income	$-2,300,500	$-2,300,500	$-2,476,000	$-2,476,000	$-2,438,000	$-2,438,000	$-1,961,500	$-1,961,500	$-1,978,500	$-1,978,500	$-1,652,000	$-1,762,000

EBITDA	$-2,339,500	$-2,339,500	$-2,525,500	$-2,525,500	$-2,437,500	$-2,437,500	$-2,015,000	$-2,015,000	$-2,046,500	$-2,046,500	$-1,830,250	$-1,861,500
EBIT	$-2,340,000	$-2,340,000	$-2,526,000	$-2,526,000	$-2,449,000	$-2,449,000	$-2,017,999	$-2,017,999	$-2,047,000	$-2,047,000	$-1,834,000	$-1,865,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about CANF

News

Can-Fite BioPharma Ltd. SEC Filing (Oct 13, 2026)

This article reports on an SEC filing by Can-Fite BioPharma Ltd. (CANF) with an effectiveness date of October 9, 2026. The filing is a Form F-3, a foreign issuer shelf registration...

Stock Titan•Oct 13, 2026 7:41 AM ET10/13/26•Neutral

CANF: Can-Fite BioPharma Ltd. Latest Stock Price, Analysis, News and Trading Ideas

This page provides the latest stock information for Can-Fite BioPharma Ltd. (CANF), including its current stock price, market capitalization...

Stocktwits•Oct 7, 2026 8:24 PM ET10/7/26•Bearish

H.C. Wainwright reiterates Can-Fite BioPharma stock rating at buy

H.C. Wainwright has reiterated a Buy rating on Can-Fite BioPharma (NYSE:CANF) and maintained an $8.00 price target...

Investing.com•Sep 29, 2026 9:32 PM ET9/29/26•Bullish

H.C. Wainwright Maintains Can-Fite BioPharma(CANF.US) With Buy Rating, Maintains Target Price $8

H.C. Wainwright has reiterated its Buy rating on Can-Fite BioPharma (CANF.US), maintaining a target price of $8. This indicates the firm's continued confidence in the company's stock performance.

Moomoo•Sep 29, 2026 9:23 PM ET9/29/26•Neutral

H.C. Wainwright reiterates Can-Fite BioPharma stock rating at buy By Investing.com

H.C. Wainwright has reiterated its Buy rating on Can-Fite BioPharma (NYSE:CANF) stock, maintaining an $8.00 price target. The stock is currently trading near its 52-week low...

Investing.com India•Sep 29, 2026 7:51 AM ET9/29/26•Bullish

CANF Valuation and Fair Value

Forward P/E: 3.0x
P/FCF: -0.8x
PEG: 0.0x
P/B: 1.5x

See GNG's fair value

CANF Profitability: Margins, ROIC and FCF

Gross margin: 100.0%
Operating margin: -2317.0%
Net margin: 0.0%
ROIC: -156.8%
ROE: -211.4%
FCF margin: -2348.9%
FCF yield: -132.8%

CANF Competitors

Company	Ticker
Evogene	EVGN
Imunon Inc	IMNN
Lexaria Bioscience Corp	LEXX
Sonoma Pharmaceuticals Inc	SNOA
Creative Medical Technology Holdings Inc	CELZ
enVVeno Medical Corp	NVNO
WORK Medical Technology Group LTD Ordinary Shares	WOK
Longeveron LLC	LGVN

Sector: Healthcare

CANF Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: -198.4%
EPS estimate (fiscal period ending Jun 30, 2026): $-0.51
Estimate revisions (30 days, fiscal period ending Jun 30, 2026): 0 up, 0 down

CANF Dividend

Forward yield: 0.0%

Frequently Asked Questions About CANF

Does CANF pay dividends?

Can Fite Biopharma Ltd ADR (CANF) has a dividend payment track record. See the CANF dividend history page for its current payment status, TTM yield, and recorded payments.

What is CANF's market cap?

Can Fite Biopharma Ltd ADR (CANF) has a market capitalization of $5.85M with a current stock price of $1.93.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In